Form 4: Astera Labs CFO Granted 11,787 RSUs

Astera Labs' Chief Financial Officer, Michael Truett Tate, was granted 11,787 restricted stock units on February 6, 2026, under the company's 2024 incentive plan.

Summary

• Michael Truett Tate, Chief Financial Officer of Astera Labs, Inc. (ALAB), was granted 11,787 shares of common stock.
• These shares represent Restricted Stock Units (RSUs) awarded on February 6, 2026, under the Astera Labs, Inc. 2024 Stock Option and Incentive Plan.
• The RSUs will vest 25% on February 15, 2027, with the remaining RSUs vesting in 12 equal quarterly installments thereafter, contingent on continuous service.
• The grant price for these RSUs was $0.
• Following this transaction, Tate directly owns 204,084 shares of common stock and indirectly owns 450,281 shares through the Tate 1997 Living Trust.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, reflecting standard executive compensation practices aimed at retaining key talent and aligning management incentives with long-term company performance.

Positives

• The grant of 11,787 Restricted Stock Units (RSUs) to the Chief Financial Officer aligns management's interests with long-term shareholder value.
• The multi-year vesting schedule encourages the long-term retention of a key executive.

Future Outlook

The vesting schedule for the RSUs extends through quarterly installments after February 15, 2027, indicating a long-term incentive structure designed to retain the Chief Financial Officer and align their performance with future company growth.

Industry Context

StockSavvy.ai notes that granting Restricted Stock Units to key executives like the CFO is a common practice across the technology and semiconductor industry. This strategy is widely adopted to incentivize performance, ensure long-term retention of critical talent, and align executive interests with shareholder value creation.

Comparison to Industry Standards

• The RSU grant structure, featuring a multi-year vesting schedule, is consistent with executive compensation practices observed in comparable high-growth technology companies.
• Companies such as NVIDIA and AMD frequently utilize similar long-term equity incentives to retain top talent and foster commitment to strategic objectives, making this grant a standard industry practice.

Related Party Transactions

• Michael Truett Tate indirectly owns 450,281 shares through the Tate 1997 Living Trust Dated April 24, 1997, of which he is a trustee. He disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein.

Stakeholder Impact

• Shareholders: Potential positive impact due to increased alignment of the CFO's interests with the company's long-term performance and strategic goals.
• Employees: May signal stability in executive leadership and a commitment to long-term growth, potentially boosting morale and confidence.

Next Steps

• 25% of the granted RSUs will vest on February 15, 2027.
• The remaining RSUs will vest in 12 equal quarterly installments thereafter, subject to continuous service.

Key Dates

Recommendation

The RSU grant to the CFO is a standard executive compensation practice aimed at retention and alignment with long-term shareholder interests. It does not present new information that would significantly alter the investment thesis for Astera Labs, Inc., thus a 'hold' recommendation is appropriate.

Keywords

Astera Labs, ALAB, Michael Truett Tate, CFO, RSU, Restricted Stock Units, Stock Grant, Executive Compensation, Insider Transaction, Form 4